Tag: ai in respiratory diseases market segments

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Current (2025) And Forecast (2029) Sizes Of The Artificial Intelligence (AI) In Respiratory Diseases Market?

The market size for artificial intelligence (AI) in respiratory diseases has demonstrated consistent expansion in recent years. It is anticipated to increase from $7.66 billion in 2024 to $7.98 billion in 2025, at a compound annual growth rate (CAGR) of 4.2%. The historical growth in this sector is largely due to increasing government regulations, growing environmental concerns, an increasing aging population, the development of patient-centric healthcare approaches, and a rise in healthcare infrastructure development.

The market size for artificial intelligence (AI) applied to respiratory diseases is projected to experience consistent expansion over the upcoming years. This market is anticipated to reach $9.7 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 5.0%. Factors driving this growth during the forecast period include the increasing incidence of respiratory ailments, the heightened demand for prompt detection and accurate diagnosis, escalating environmental contamination, increasing spending on healthcare, and ongoing research and development efforts. Key trends anticipated in the forecast period encompass advancements in technology, innovations in drug discovery and development, the adoption of tailored treatment strategies, and the expansion of telemedicine and remote patient monitoring.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13792&type=smp

Which Drivers Are Shaping The Artificial Intelligence (AI) In Respiratory Diseases Industry’s Market Share?

The increasing problem of environmental pollution is anticipated to drive the expansion of artificial intelligence (AI) within the respiratory disease market in the future. Environmental pollution is defined as the introduction of substances or energy into the environment at a pace exceeding its capacity for harmless dispersion or storage. AI’s application in respiratory diseases can considerably lessen environmental pollution’s effects on respiratory health by providing real-time surveillance, individualized risk evaluations, well-informed choices, and novel approaches for both people and populations. For example, data from June 2024, provided by the US Energy Information Administration, a governmental body in the US, indicated that CO2 emissions reached 35.72 billion metric tons in 2021, subsequently rising to 38.50 billion metric tons in 2022. Consequently, the rise in environmental pollution is stimulating the development of artificial intelligence (AI) in the respiratory disease market.

What Are The Key Segments In The Artificial Intelligence (AI) In Respiratory Diseases Market?

The artificial intelligence (AI) in respiratory diseasesmarket covered in this report is segmented –

1) By Imaging Type: Magnetic Resonance Imaging (MRI); Computed Tomography (CT) Scan; Electronic Patient-Reported Outcomes (ePRO)

2) By Indication: Chronic Obstructive Pulmonary Disease; Interstitial Lung Disease; Pulmonary Infection

3) By End Use: Hospital; Diagnostic Centers; Ambulatory Surgical Centers; Other End-Users

Subsegments:

1) By Magnetic Resonance Imaging (MRI): Lung Imaging; Thoracic Imaging; Cardiopulmonary Imaging

2) By Computed Tomography (CT) Scan: High-Resolution CT (HRCT); Low-Dose CT; Thoracic CT

3) By Electronic Patient-Reported Outcomes (ePRO): Symptom Tracking; Medication Adherence Monitoring; Quality Of Life Assessments

What Long-Term Trends Will Shape The Future Growth Of The Artificial Intelligence (AI) In Respiratory Diseases Industry?

Leading companies active in the artificial intelligence (AI) in the respiratory diseases market are developing innovative products, such as N-Tidal devices, to monitor patients’ tidal breathing. The N-Tidal device quantifies the volume of air exchanged during normal breathing, offering crucial information regarding lung function. For instance, in August 2023, TidalSense, a UK-based respiratory technology company, launched N-Tidal, a regulated AI technology specifically for chronic obstructive pulmonary disease (COPD) diagnosis and management. This technology integrates N-Tidal’s CO2 sensor data with an artificial intelligence platform to measure changes in lung function, aiming to refine the diagnosis and management of this particular respiratory condition. Clinical studies have showcased the technology’s high accuracy, and it is projected to revolutionize the diagnostic process for respiratory diseases. This introduction represents a significant stride in leveraging AI for respiratory disease assessment, presenting a more comfortable and efficient substitute for current diagnostic tests.

Who Are The Major Companies Operating In The Artificial Intelligence (AI) In Respiratory Diseases Market?

Major companies operating in the artificial intelligence (AI) in respiratory diseases market report are Siemens Healthineers, Philips Healthcare, General Electric (GE) Healthcare, Verily Life Sciences LLC, DeepMind Health, Merative L.P., Innovaccer, Freenome, Aidoc Medical, Butterfly Network, Infervision, Imagen Technologies, Caption Health, Gauss Surgical Inc., Swaasa AI, Inspirata Inc., VIDA Diagnostics Inc., Enlitic, Thirona B.v., ArtiQ, Icometrix, Zynnon AG, Aidence, Arterys, Dectrocel Healthcare, PneumoWave Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-respiratory-diseases-global-market-report

Which Region Shows The Highest Potential For Future Expansion In The Artificial Intelligence (AI) In Respiratory Diseases Market?

North America was the largest region in the artificial Intelligence (AI) in respiratory diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in respiratory diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Artificial Intelligence (AI) In Respiratory Diseases Market Report:

https://www.thebusinessresearchcompany.com/customise?id=13792&type=smp

Browse Through More Reports Similar to the Global Artificial Intelligence (AI) In Respiratory Diseases Market 2025, By The Business Research Company

Artificial Intelligence Of Things Aiot Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-of-things-aiot-global-market-report

Artificial Intelligence In Cancer Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-cancer-diagnostics-global-market-report

Artificial Intelligence Ai Engineering Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-engineering-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Artificial Intelligence (AI) In Respiratory Diseases Market Size Shifted, And What Is the Outlook Through 2034?

The market size of artificial intelligence (AI) applied to respiratory diseases has been on a consistent rise over the past few years. The value of the market is predicted to increase from $7.66 billion in 2024 to $7.98 billion in 2025, recording a compound annual growth rate (CAGR) of 4.2%. This growth trend during the historical period is primarily due to a rise in government regulations, enhanced environmental awareness, a surge in the elderly population, a shift towards patient-centered healthcare models, and an escalation in the development of healthcare infrastructure.

The market size for artificial intelligence (AI) in respiratory diseases is predicted to experience consistent growth in the coming years, reaching a value of$9.7 billion in 2029 with a compound annual growth rate (CAGR) of 5.0%. This predicted growth throughout the forecast period can be linked to a rise in respiratory disease prevalence, an increased demand for early detection and diagnosis, escalating environmental pollution, growing healthcare expenses, and ongoing research and development efforts. Notable trends expected during the forecast period comprise technological evolution, drug discovery and creation, individualized treatment methodologies, the use of telemedicine and remote patient monitoring methodologies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13792&type=smp

Which Primay Drivers Are Accelerating Growth in the Artificial Intelligence (AI) In Respiratory Diseases Market?

The escalating issue of environmental pollution is anticipated to fuel the expansion of artificial intelligence (AI) in the respiratory disease market. Environmental pollution is typically characterized by the accumulation of substances or energy forms in the environment at a pace quicker than they can be safely dispersed or stored. The application of AI in respiratory diseases can drastically minimize the repercussions of environmental pollution on respiratory health. This is done by providing real-time monitoring, personalized risk evaluations, informed decision making, and pioneering solutions for individuals and communities alike. For example, data from the US Energy Information Administration, a government agency based in the US, indicated that in June 2024, the level of CO2 emissions in 2021 was at 35.72 billion metric tons, jumping to 38.50 billion metric tons in 2022. Consequently, the rising environmental pollution is spurring the development of artificial intelligence (AI) in the respiratory disease market.

Which Primary Segments of the Artificial Intelligence (AI) In Respiratory Diseases Market Are Driving Growth and Industry Transformations?

The artificial intelligence (AI) in respiratory diseasesmarket covered in this report is segmented –

1) By Imaging Type: Magnetic Resonance Imaging (MRI); Computed Tomography (CT) Scan; Electronic Patient-Reported Outcomes (ePRO)

2) By Indication: Chronic Obstructive Pulmonary Disease; Interstitial Lung Disease; Pulmonary Infection

3) By End Use: Hospital; Diagnostic Centers; Ambulatory Surgical Centers; Other End-Users

Subsegments:

1) By Magnetic Resonance Imaging (MRI): Lung Imaging; Thoracic Imaging; Cardiopulmonary Imaging

2) By Computed Tomography (CT) Scan: High-Resolution CT (HRCT); Low-Dose CT; Thoracic CT

3) By Electronic Patient-Reported Outcomes (ePRO): Symptom Tracking; Medication Adherence Monitoring; Quality Of Life Assessments

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=13792&type=smp

Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Artificial Intelligence (AI) In Respiratory Diseases Market?# Market?

North America was the largest region in the artificial Intelligence (AI) in respiratory diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in respiratory diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Technological Trends Are Reshaping the Artificial Intelligence (AI) In Respiratory Diseases Industry Dynamics?

Leading corporations in the artificial intelligence (AI) sector of the respiratory diseases market are advancing in the development of specialized products like the N-Tidal devices, used for monitoring tidal breathing in patients. With the help of the n-Tidal device, the volume of air exchanged in regular breathing can be measured, offering essential insights into the functioning of the lungs. For example, TidalSense, a UK-based company specializing in respiratory technology, released an AI-based technology, N-Tidal, in August 2023. This technology incorporates N-Tidal’s CO2 sensor data into an AI platform for the diagnosis and management of chronic obstructive pulmonary disease (COPD). This strategic combination is aimed at enhancing the monitoring of lung function changes, thereby improving the diagnosis and handling of this respiratory disease. Clinical trials indicate high accuracy levels of this technology, which is set to revolutionize the method of diagnosing respiratory diseases. This breakthrough marks substantial progress in utilizing AI for the evaluation of respiratory diseases, presenting a remarkably more comfortable and efficient alternative to existing diagnostic procedures.

View the full report here:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-respiratory-diseases-global-market-report

What Parameters Are Used to Define the Artificial Intelligence (AI) In Respiratory Diseases Market?

Artificial intelligence (AI) in respiratory diseases refers to the use of AI and machine learning techniques to aid clinicians in the diagnosis, management, and treatment of various respiratory conditions. It has numerous potential applications in pulmonary medicine, including image analysis, predictive modeling, and disease management.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13792

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Artificial Intelligence (AI) In Respiratory Diseases Market Size Changed, over the years?

The market size for artificial intelligence (AI) in respiratory diseases has seen substantial growth in the past few years. The market is projected to expand from $7.66 billion in 2024 to $8.05 billion in 2025, indicating a compound annual growth rate (CAGR) of 5.1%. Factors contributing to the historical growth include tightening government regulations, rising environmental concerns, an increasing older population, the evolution towards patient-focused healthcare practices and the escalation in healthcare infrastructure development.

How Much Will the Artificial Intelligence (AI) In Respiratory Diseases Market Be Worth in 2029?

In the coming years, the market for artificial intelligence (AI) in respiratory diseases is predicted to witness robust growth. The market is estimated to reach a value of $9.85 billion by 2029, growing at a compound annual growth rate (CAGR) of 5.2%. Factors contributing to this growth during the forecast period include rising cases of respiratory diseases, the increasing demand for early detection and diagnosis, escalating environmental pollution, growing healthcare expenditures, as well as research and development efforts. The forecast period is also set to see major trends like technological advancements, drug discovery and development, personalization of treatment strategies, the advent of telemedicine and remote patient monitoring.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13792&type=smp

Which is the Largest Company in the Artificial Intelligence (AI) In Respiratory Diseases Market?

Major companies operating in the artificial intelligence (AI) in respiratory diseases market report are Siemens Healthineers, Philips Healthcare, General Electric (GE) Healthcare, Verily Life Sciences LLC, DeepMind Health, Merative L.P., Innovaccer, Freenome, Aidoc Medical, Butterfly Network, Infervision, Imagen Technologies, Caption Health, Gauss Surgical Inc., Swaasa AI, Inspirata Inc., VIDA Diagnostics Inc., Enlitic, Thirona B.v., ArtiQ, Icometrix, Zynnon AG, Aidence, Arterys, Dectrocel Healthcare, PneumoWave Ltd.

What Are the Main Market Drivers in the Artificial Intelligence (AI) In Respiratory Diseases Industry?

The escalation of environmental pollution is predicted to stimulate the expansion of artificial intelligence (AI) in the respiratory disease market. Environmental pollution involves introducing substances or energy to the environment at a pace that outstrips its safe dispersion or storage capacity. AI can potentially mitigate the adverse effects of environmental pollution on respiratory health through real-time surveillance, individualized risk evaluations, enlightened decision-making, and inventive solutions for people and communities. For example, the US Energy Information Administration, an American government entity, recorded that the CO2 emission in 2021 amounted to 35.72 billion metric tons and escalated to 38.50 billion metric tons in 2022 as recorded in June 2024. Consequently, the burgeoning environmental pollution is fostering the growth of artificial intelligence (AI) in the respiratory disease market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13792&type=smp

How Is the Artificial Intelligence (AI) In Respiratory Diseases Market Segments Structured?

The artificial intelligence (AI) in respiratory diseases market covered in this report is segmented –

1) By Imaging Type: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electronic Patient-Reported Outcomes (ePRO)

2) By Indication: Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection

3) By End Use: Hospital, Diagnostic Centers, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Magnetic Resonance Imaging (MRI): Lung Imaging, Thoracic Imaging, Cardiopulmonary Imaging

2) By Computed Tomography (CT) Scan: High-Resolution CT (HRCT), Low-Dose CT, Thoracic CT

3) By Electronic Patient-Reported Outcomes (ePRO): Symptom Tracking, Medication Adherence Monitoring, Quality Of Life Assessments

What Strategic Trends Are Transforming the Artificial Intelligence (AI) In Respiratory Diseases Market?

Major firms in the respiratory diseases market that focus on artificial intelligence (AI) are introducing innovative solutions such as N-Tidal devices to track patients’ tidal breathing. The n-Tidal device gauges the amount of air exchanged during regular respiration, offering critical insights into lung activity. For example, in August 2023, TidalSense, a UK-based firm specializing in respiratory technology, launched N-Tidal, a regulated AI solution for diagnosing and managing chronic obstructive pulmonary disease (COPD). The tech merges N-Tidal’s CO2 sensor data with an AI platform to spot changes in lung activity, with the goal of enhancing COPD diagnosis and management. Clinical trials have shown this technology to be highly accurate, and it’s poised to revolutionize the diagnostic procedure for respiratory ailments. This introduction marks a crucial advancement in the application of AI for respiratory disease evaluation, providing a more efficient, pleasant alternative to present diagnostic procedures.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-respiratory-diseases-global-market-report

Which Global Regions Offer the Highest Growth in the Artificial Intelligence (AI) In Respiratory Diseases Market?

North America was the largest region in the artificial Intelligence (AI) in respiratory diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in respiratory diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13792

This Report Delivers Insight On:

1. How big is the artificial intelligence (ai) in respiratory diseases market, and how is it changing globally?

2. Who are the major companies in the artificial intelligence (ai) in respiratory diseases market, and how are they performing?

3. What are the key opportunities and risks in the artificial intelligence (ai) in respiratory diseases market right now?

4. Which products or customer segments are growing the most in the artificial intelligence (ai) in respiratory diseases market?

5. What factors are helping or slowing down the growth of the artificial intelligence (ai) in respiratory diseases market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the artificial intelligence (ai) in respiratory diseases industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Is the Current and Projected Market Size of the Artificial Intelligence (AI) In Respiratory Diseases Market Through 2034?

The market size for artificial intelligence (AI) applications in respiratory diseases has seen substantial growth in the last few years. The market is projected to expand from $7.66 billion in 2024 to $8.05 billion in 2025, achieving a compound annual growth rate (CAGR) of 5.1%. This growth in previous years can be traced back to factors such as stricter government rules, increasing awareness about the environment, a rise in the elderly population, emergence of patient-focused healthcare methods, and the expansion of healthcare infrastructure.

The market size of artificial intelligence (AI) in respiratory diseases is anticipated to experience robust growth in the coming years. It is projected to attain a value of $9.85 billion by 2029, with a compound annual growth rate (CAGR) of 5.2%. The predicted growth during the forecast period can be linked with the rising prevalence of respiratory diseases, the escalating needs for early detection and diagnosis, increasing environmental pollution, heightened spending on healthcare, and ongoing research and development initiatives. Key trends expected within the forecast period encompass technology advancements, drug discovery and development, personalized treatment plans, telemedicine and remote patient monitoring.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13792&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Artificial Intelligence (AI) In Respiratory Diseases Market?

The rise of environmental pollution is anticipated to spur the growth of artificial intelligence (AI) in the respiratory disease domain. The term environmental pollution pertains to any substance or form of energy added to the environment at a quicker pace than its harmless dispersion or storage. AI exhibits promise in substantially diminishing the repercussions of environmental pollution on respiratory wellness, through real-time surveillance, customized risk evaluations, informed decision making, and breakthrough solutions dedicated to individuals as well as communities. For instance, as reported by the US Energy Information Administration, a government agency based in the US, the CO2 emission in 2021 racked up to 35.72 billion metric tons, escalating to 38.50 billion metric tons in 2022 in June 2024. Consequently, the mounting environmental pollution is fuelling the growth of AI applications in the respiratory disease sector.

Which Key Market Segments Comprise the Artificial Intelligence (AI) In Respiratory Diseases Market and Drive Its Revenue Growth?

The artificial intelligence (AI) in respiratory diseases market covered in this report is segmented –

1) By Imaging Type: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electronic Patient-Reported Outcomes (ePRO)

2) By Indication: Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection

3) By End Use: Hospital, Diagnostic Centers, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Magnetic Resonance Imaging (MRI): Lung Imaging, Thoracic Imaging, Cardiopulmonary Imaging

2) By Computed Tomography (CT) Scan: High-Resolution CT (HRCT), Low-Dose CT, Thoracic CT

3) By Electronic Patient-Reported Outcomes (ePRO): Symptom Tracking, Medication Adherence Monitoring, Quality Of Life Assessments

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=13792&type=smp

Which Areas Are Leading Regions in the Artificial Intelligence (AI) In Respiratory Diseases Market Expansion Across the Globe?

North America was the largest region in the artificial Intelligence (AI) in respiratory diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in respiratory diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Key Market Trends in the Artificial Intelligence (AI) In Respiratory Diseases Market Over the Coming Years?

Leading firms operating in the respiratory diseases market are focusing on Artificial Intelligence (AI) to devise innovative tools like N-Tidal devices that can track tidal breathing in patients. These devices measure the airflow during normal respiratory activity, which assists in evaluating lung performance. TidalSense, a British respiratory technology firm, introduced an N-Tidal regulated AI system for diagnosing and managing Chronic Obstructive Pulmonary Disease (COPD) in August 2023. This distinctive technology merges the CO2 sensor data from N-Tidal with an AI platform to identify alterations in lung performance. This aims to significantly enhance COPD’s diagnosis and management. Clinical research has confirmed the system’s superior accuracy, promising to revolutionize the diagnosis process for respiratory conditions. This development indicates a meaningful advancement in incorporating AI in assessing respiratory diseases, as it offers an easier and more efficient substitute for traditional diagnostic procedures.

View the full report here:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-respiratory-diseases-global-market-report

How Is the Artificial Intelligence (AI) In Respiratory Diseases Market Conceptually Defined?

Artificial intelligence (AI) in respiratory diseases refers to the use of AI and machine learning techniques to aid clinicians in the diagnosis, management, and treatment of various respiratory conditions. It has numerous potential applications in pulmonary medicine, including image analysis, predictive modeling, and disease management.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13792

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Artificial Intelligence (AI) In Respiratory Diseases Market?

The escalation of environmental pollution is set to boost the advancement of artificial intelligence (AI) within the respiratory disease market. This type of pollution involves the accumulation of substances or energy forms more rapidly than they can be scattered or stored in a safe manner. AI has the ability to considerably lessen the effects of environmental pollution on respiratory health, providing real-time monitoring, personalized risk evaluations, informed decision-making, and groundbreaking solutions for both individuals and communities. For example, the US Energy Information Administration – a government agency in the States, reported that in June 2024, the CO2 emissions for 2021 were 35.72 billion metric tons, escalating to 38.5 billion metric tons in 2022. This indicates that the growing issue of environmental pollution is propelling the progression of AI in the respiratory disease market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13792&type=smp

#What Growth Opportunities Will Drive the Artificial Intelligence (AI) In Respiratory Diseases Market’s CAGR Through 2034?

The market size of artificial intelligence (AI) in respiratory diseases has seen significant expansion in recent times. Its growth is projected to escalate from $7.66 billion in 2024 to $8.05 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.1%. The historical growth can be linked to factors such as stringent government regulations, amplified concerns about the environment, rising aging population, expansion in patient-centric healthcare strategies, and a boom in healthcare infrastructure development.

The market size for artificial intelligence (AI) in respiratory diseases is projected to experience a robust expansion in the forthcoming years, reaching a value of $9.85 billion by 2029, growing at a compound annual growth rate (CAGR) of 5.2%. Factors contributing to this surge during the forecast period include an increasing occurrence of respiratory diseases, the escalating demand for early recognition and treatment, the growth in environmental pollution, mounting healthcare expenditure, and research and development initiatives. Notable trends for the forecast period encompass technological innovations, drug discovery and development, customized treatment methods, telemedicine, and remote patient monitoring.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13792

What Are the Key Market Innovations in theArtificial Intelligence (AI) In Respiratory Diseases Market Over the Coming Years?

Prominent entities in the domain of artificial intelligence (AI) within the respiratory diseases market are introducing ground-breaking products like N-Tidal devices to monitor the tidal breathing of patients. The N-Tidal device calculates the volume of air transferred during normal breathing, delivering critical insights into lung function. TidalSense, a British respiratory technology firm, unveiled N-Tidal in August 2023 for example – a controlled AI technology for diagnosing and managing chronic obstructive pulmonary disease (COPD). The technology syncs N-Tidal’s CO2 sensor data with an AI platform to evaluate alterations in lung function, with a goal to enhance COPD diagnosis and management. The demonstrated high accuracy of the technology in clinical trials is poised to revolutionize the diagnostic methods for respiratory diseases. This launch marks a notable progress in the application of AI for assessing respiratory diseases, presenting a more convenient and effective replacement to current diagnostic examinations.

Who Are the Top Companies Driving Innovation and Growth in theArtificial Intelligence (AI) In Respiratory Diseases Market?

Major companies operating in the artificial intelligence (AI) in respiratory diseases market report are Siemens Healthineers, Philips Healthcare, General Electric (GE) Healthcare, Verily Life Sciences LLC, DeepMind Health, Merative L.P., Innovaccer, Freenome, Aidoc Medical, Butterfly Network, Infervision, Imagen Technologies, Caption Health, Gauss Surgical Inc., Swaasa AI, Inspirata Inc., VIDA Diagnostics Inc., Enlitic, Thirona B.v., ArtiQ, Icometrix, Zynnon AG, Aidence, Arterys, Dectrocel Healthcare, PneumoWave Ltd.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-respiratory-diseases-global-market-report

Which Key Market Segments Comprise the Artificial Intelligence (AI) In Respiratory Diseases Market and Drive Its Revenue Growth?

The artificial intelligence (AI) in respiratory diseases market covered in this report is segmented –

1) By Imaging Type: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electronic Patient-Reported Outcomes (ePRO)

2) By Indication: Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection

3) By End Use: Hospital, Diagnostic Centers, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Magnetic Resonance Imaging (MRI): Lung Imaging, Thoracic Imaging, Cardiopulmonary Imaging

2) By Computed Tomography (CT) Scan: High-Resolution CT (HRCT), Low-Dose CT, Thoracic CT

3) By Electronic Patient-Reported Outcomes (ePRO): Symptom Tracking, Medication Adherence Monitoring, Quality Of Life Assessments

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=13792&type=smp

Which Regions Are Emerging as Leaders in the Artificial Intelligence (AI) In Respiratory Diseases Market?

North America was the largest region in the artificial Intelligence (AI) in respiratory diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in respiratory diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Artificial Intelligence (AI) In Respiratory Diseases Market 2025, By The Business Research Company:

Artificial Intelligence in Healthcare Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-global-market-report

Artificial Intelligence Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-services-global-market-report

Artificial Intelligence In Magnetic Resonance Imaging (MRI) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-magnetic-resonance-imaging-mri-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What key factors are powering the surge in the artificial intelligence (ai) in respiratory diseases market right now?

The market for artificial intelligence (AI) in respiratory illness has been expanding firmly over the past few years. It is projected to increase from $7.66 billion in 2024 to $8.05 billion in 2025, indicating a compound annual growth rate (CAGR) of 5.1%. The expansion during the historic period can be credited to factors such as heightened government regulations, growing concerns about the environment, an increasing elderly population, a surge in patient-focused healthcare strategies, and a rise in the development of healthcare infrastructure.

How fast Is the artificial intelligence (ai) in retail market expected to grow, and what’s its future value?

The market size of artificial intelligence (AI) in the area of respiratory diseases is projected to experience significant growth in the forthcoming years. It is anticipated to reach $9.85 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 5.2%. Factors contributing to this predicted growth during the forecast period include an increasing number of respiratory disease cases, a heightened demand for early detection and diagnosis, escalating environmental pollution, rising healthcare spending, and research and development efforts. Futures trends predicted for this period encompass technological innovations, drug discovery and enhancement, individualized treatment strategies, the adoption of telemedicine and remote patient monitoring.

Get your artificial intelligence (ai) in respiratory diseases market report here!

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-respiratory-diseases-global-market-report

What are the leading drivers of growth in the artificial intelligence (ai) in respiratory diseases market?

The escalating issue of environmental contamination is predicted to boost the expansion of artificial intelligence (AI) in the respiratory disease market. This type of pollution occurs when the rate of contaminants or energy added to the environment outpaces the rate at which they can be neutralized or stored safely. By providing real-time monitoring, customized risk evaluations, evidence-based decision-making, and creative solutions, AI in respiratory diseases could markedly mitigate the effects of environmental contamination on respiratory health for both individuals and communities. For example, the US Energy Information Administration, a government agency, reported that CO2 emissions were 35.72 billion metric tons in 2021 and rose to 38.50 billion metric tons in 2022. Consequently, the escalating environmental pollution is spurring the expansion of artificial intelligence (AI) in the respiratory disease market.

What are the key segments defining the artificial intelligence (ai) in respiratory diseases market?

The artificial intelligence (AI) in respiratory diseases market covered in this report is segmented –

1) By Imaging Type: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electronic Patient-Reported Outcomes (ePRO)

2) By Indication: Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection

3) By End Use: Hospital, Diagnostic Centers, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Magnetic Resonance Imaging (MRI): Lung Imaging, Thoracic Imaging, Cardiopulmonary Imaging

2) By Computed Tomography (CT) Scan: High-Resolution CT (HRCT), Low-Dose CT, Thoracic CT

3) By Electronic Patient-Reported Outcomes (ePRO): Symptom Tracking, Medication Adherence Monitoring, Quality Of Life Assessments

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13792&type=smp

Who are the key players steering the development of the artificial intelligence (ai) in respiratory diseases market?

Major companies operating in the artificial intelligence (AI) in respiratory diseases market report are Siemens Healthineers, Philips Healthcare, General Electric (GE) Healthcare, Verily Life Sciences LLC, DeepMind Health, Merative L.P., Innovaccer, Freenome, Aidoc Medical, Butterfly Network, Infervision, Imagen Technologies, Caption Health, Gauss Surgical Inc., Swaasa AI, Inspirata Inc., VIDA Diagnostics Inc., Enlitic, Thirona B.v., ArtiQ, Icometrix, Zynnon AG, Aidence, Arterys, Dectrocel Healthcare, PneumoWave Ltd.

What emerging trends are influencing the growth of the artificial intelligence (ai) in respiratory diseases market?

Leading corporations in the respiratory diseases market using artificial intelligence (AI) are pushing the boundaries by creating groundbreaking products like N-Tidal devices that track a patient’s tidal breathing. These devices help gauge the amount of air transferred during normal respiration, thereby offering crucial insights into lung functionality. For instance, TidalSense, a respiratory technology firm based in the UK, unveiled its regulated AI technology, N-Tidal, in August 2023. This technology, designed for chronic obstructive pulmonary disease (COPD) diagnosis and administration, marries the CO2 sensor data from N-Tidal with an AI platform to monitor variations in lung functionality. It aims to enhance both the diagnosis and management of this respiratory condition. Clinical trials have reaffirmed the high precision of this technology, which is predicted to revolutionize the diagnostic procedure for respiratory diseases. Its introduction marks a pivotal step in applying AI to assess respiratory diseases, offering a more convenient and effective substitute to current diagnostic trials.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13792

Which regions are most influential in expanding the artificial intelligence (ai) in respiratory diseases market?

North America was the largest region in the artificial Intelligence (AI) in respiratory diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in respiratory diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Artificial Intelligence in Healthcare Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-global-market-report

Artificial Intelligence Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-services-global-market-report

Artificial Intelligence In Magnetic Resonance Imaging (MRI) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-magnetic-resonance-imaging-mri-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What key factors are powering the surge in the artificial intelligence (ai) in respiratory diseases market right now?

The market for artificial intelligence (AI) in respiratory illness has been expanding firmly over the past few years. It is projected to increase from $7.66 billion in 2024 to $8.05 billion in 2025, indicating a compound annual growth rate (CAGR) of 5.1%. The expansion during the historic period can be credited to factors such as heightened government regulations, growing concerns about the environment, an increasing elderly population, a surge in patient-focused healthcare strategies, and a rise in the development of healthcare infrastructure.

How fast Is the artificial intelligence (ai) in retail market expected to grow, and what’s its future value?

The market size of artificial intelligence (AI) in the area of respiratory diseases is projected to experience significant growth in the forthcoming years. It is anticipated to reach $9.85 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 5.2%. Factors contributing to this predicted growth during the forecast period include an increasing number of respiratory disease cases, a heightened demand for early detection and diagnosis, escalating environmental pollution, rising healthcare spending, and research and development efforts. Futures trends predicted for this period encompass technological innovations, drug discovery and enhancement, individualized treatment strategies, the adoption of telemedicine and remote patient monitoring.

Get your artificial intelligence (ai) in respiratory diseases market report here!

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-respiratory-diseases-global-market-report

What are the leading drivers of growth in the artificial intelligence (ai) in respiratory diseases market?

The escalating issue of environmental contamination is predicted to boost the expansion of artificial intelligence (AI) in the respiratory disease market. This type of pollution occurs when the rate of contaminants or energy added to the environment outpaces the rate at which they can be neutralized or stored safely. By providing real-time monitoring, customized risk evaluations, evidence-based decision-making, and creative solutions, AI in respiratory diseases could markedly mitigate the effects of environmental contamination on respiratory health for both individuals and communities. For example, the US Energy Information Administration, a government agency, reported that CO2 emissions were 35.72 billion metric tons in 2021 and rose to 38.50 billion metric tons in 2022. Consequently, the escalating environmental pollution is spurring the expansion of artificial intelligence (AI) in the respiratory disease market.

What are the key segments defining the artificial intelligence (ai) in respiratory diseases market?

The artificial intelligence (AI) in respiratory diseases market covered in this report is segmented –

1) By Imaging Type: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electronic Patient-Reported Outcomes (ePRO)

2) By Indication: Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection

3) By End Use: Hospital, Diagnostic Centers, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Magnetic Resonance Imaging (MRI): Lung Imaging, Thoracic Imaging, Cardiopulmonary Imaging

2) By Computed Tomography (CT) Scan: High-Resolution CT (HRCT), Low-Dose CT, Thoracic CT

3) By Electronic Patient-Reported Outcomes (ePRO): Symptom Tracking, Medication Adherence Monitoring, Quality Of Life Assessments

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13792&type=smp

Who are the key players steering the development of the artificial intelligence (ai) in respiratory diseases market?

Major companies operating in the artificial intelligence (AI) in respiratory diseases market report are Siemens Healthineers, Philips Healthcare, General Electric (GE) Healthcare, Verily Life Sciences LLC, DeepMind Health, Merative L.P., Innovaccer, Freenome, Aidoc Medical, Butterfly Network, Infervision, Imagen Technologies, Caption Health, Gauss Surgical Inc., Swaasa AI, Inspirata Inc., VIDA Diagnostics Inc., Enlitic, Thirona B.v., ArtiQ, Icometrix, Zynnon AG, Aidence, Arterys, Dectrocel Healthcare, PneumoWave Ltd.

What emerging trends are influencing the growth of the artificial intelligence (ai) in respiratory diseases market?

Leading corporations in the respiratory diseases market using artificial intelligence (AI) are pushing the boundaries by creating groundbreaking products like N-Tidal devices that track a patient’s tidal breathing. These devices help gauge the amount of air transferred during normal respiration, thereby offering crucial insights into lung functionality. For instance, TidalSense, a respiratory technology firm based in the UK, unveiled its regulated AI technology, N-Tidal, in August 2023. This technology, designed for chronic obstructive pulmonary disease (COPD) diagnosis and administration, marries the CO2 sensor data from N-Tidal with an AI platform to monitor variations in lung functionality. It aims to enhance both the diagnosis and management of this respiratory condition. Clinical trials have reaffirmed the high precision of this technology, which is predicted to revolutionize the diagnostic procedure for respiratory diseases. Its introduction marks a pivotal step in applying AI to assess respiratory diseases, offering a more convenient and effective substitute to current diagnostic trials.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13792

Which regions are most influential in expanding the artificial intelligence (ai) in respiratory diseases market?

North America was the largest region in the artificial Intelligence (AI) in respiratory diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in respiratory diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Artificial Intelligence in Healthcare Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-global-market-report

Artificial Intelligence Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-services-global-market-report

Artificial Intelligence In Magnetic Resonance Imaging (MRI) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-magnetic-resonance-imaging-mri-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Factors Are Driving the Anticipated Growth Rate of the Artificial Intelligence (AI) In Respiratory Diseases Market Through 2034?

In recent times, the artificial intelligence (AI) market for respiratory diseases has exhibited robust growth. Projections indicate an increase from $7.66 billion in 2024 to $8.05 billion in 2025, translating to a compound annual growth rate (CAGR) of 5.1%. Factors driving this growth during the historic period include amplified governmental directives, growing ecological concerns, a rise in the aging population, an increase towards patient-focused healthcare strategies, and enhanced healthcare infrastructure development.

The market for artificial intelligence (AI) in respiratory diseases is predicted to witness robust expansion in the upcoming years, anticipating a growth to $9.85 billion by 2029 with a compound annual growth rate (CAGR) of 5.2%. Factors contributing to this projected growth during the forecast period include an upsurge in respiratory diseases, increasing necessity for early detection and diagnosis, escalating environmental pollution, rising healthcare expenditure, and research and development efforts. Notable trends for the forecast period encompass technology evolution, drug discovery and formulation, tailored treatment schemes, telemedicine, and offsite patient supervision.

Which Drivers Are Expected to Have the Greatest Impact on the artificial intelligence (ai) in respiratory diseases Market’s Growth?

The rise in environmental contamination is anticipated to fuel the expansion of the artificial intelligence (AI) application in the respiratory ailment market. Environmental contamination is when substances or energy forms are added to the environment at a pace faster than they can be safely dispersed or stored. AI has the potential to substantially mitigate the effects of environmental pollution on respiratory health, providing real-time surveillance, personalized risk evaluations, informed decision-making, and inventive solutions for both individuals and groups. The US Energy Information Administration, an American government institution, declared in June 2024 that the CO2 emissions for 2021 amounted to 35.72 billion metric tons, which surged to 38.50 billion metric tons in 2022. Consequently, the escalation of environmental contamination is stimulating the expansion of the AI in the respiratory ailment market.

Get Your Free Sample of the Global Artificial Intelligence (AI) In Respiratory Diseases Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=13792&type=smp

Who Are the Major Industry Leaders Accelerating Growth in the Artificial Intelligence (AI) In Respiratory Diseases Market?

Major companies operating in the artificial intelligence (AI) in respiratory diseases market report are:

• Siemens Healthineers_x000D_

• Philips Healthcare_x000D_

• General Electric (GE) Healthcare_x000D_

• Verily Life Sciences LLC_x000D_

• DeepMind Health_x000D_

Which Current Trends Are Having the Most Impact on the Artificial Intelligence (AI) In Respiratory Diseases Market?

Leading companies that are active in the artificial intelligence (AI) sector within the respiratory diseases field are introducing revolutionary products, such as N-Tidal devices, to keep track of patients’ tidal respiration. The n-Tidal gadget calculates the amount of air transferred during regular respiration, offering precious insights into lung health. For instance, TidalSense, a respiratory technologies firm based in the UK, unveiled N-Tidal in August 2023. This is a controlled AI system used for diagnosing and managing chronic obstructive pulmonary disease (COPD). The system harnesses the CO2 sensor data from N-Tidal in conjunction with an artificial intelligence platform to record variations in lung function, with the objective of enhancing the diagnosis and management of respiratory diseases. Clinical research attests to the high precision of this technology, which is poised to revolutionize the procedure for diagnosing respiratory illnesses. The introduction of this technology marks a major step forward in the application of AI in assessing respiratory diseases, presenting a more convenient and efficient replacement to current diagnostic procedures.

Get Instant Access to the Global Artificial Intelligence (AI) In Respiratory Diseases Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-respiratory-diseases-global-market-report

What Major Market Segments Define the Scope and Growth of the Artificial Intelligence (AI) In Respiratory Diseases Market?

The artificial intelligence (AI) in respiratory diseases market covered in this report is segmented –

1) By Imaging Type: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electronic Patient-Reported Outcomes (ePRO)

2) By Indication: Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection

3) By End Use: Hospital, Diagnostic Centers, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Magnetic Resonance Imaging (MRI): Lung Imaging, Thoracic Imaging, Cardiopulmonary Imaging

2) By Computed Tomography (CT) Scan: High-Resolution CT (HRCT), Low-Dose CT, Thoracic CT

3) By Electronic Patient-Reported Outcomes (ePRO): Symptom Tracking, Medication Adherence Monitoring, Quality Of Life Assessments

Which Regions Are Key Players in the Growth of the Artificial Intelligence (AI) In Respiratory Diseases Market?

North America was the largest region in the artificial Intelligence (AI) in respiratory diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in respiratory diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Elements Shape the Definition of the Artificial Intelligence (AI) In Respiratory Diseases Market?

Artificial intelligence (AI) in respiratory diseases refers to the use of AI and machine learning techniques to aid clinicians in the diagnosis, management, and treatment of various respiratory conditions. It has numerous potential applications in pulmonary medicine, including image analysis, predictive modeling, and disease management.

Browse Through More Similar Reports By The Business Research Company:

Artificial Intelligence in Healthcare Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-global-market-report

Artificial Intelligence Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-services-global-market-report

Artificial Intelligence In Magnetic Resonance Imaging (MRI) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-magnetic-resonance-imaging-mri-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: